Microbiome to Medicine®

Second Genome's proprietary Microbiome Discovery Platform uniquely addresses current limitations in target discovery and validation by:

• Integrating computational science and machine learning with human disease biology to redefine diseases
• Building and maintaining structured databases of public and proprietary datasets
• Generating libraries of compounds that are screened in traditional drug discovery and development assays